Detection of spatially regulated gene expression by hybridization histochemistry.
Steady state measurements of kidney androgen-regulated protein (KAP) mRNA suggested that KAP gene expression was unusually sensitive to low hormone-receptor levels. Two of the criteria used to reach this conclusion involved relative insensitivity to treatment with a competitive antiandrogen and a partial androgen response of the gene in Tfm/Y androgen receptor (AR) deficient mice. These data may indicate the ability of the KAP gene to respond to an extremely low level of androgen-AR complex or that the effect of androgens is, at least in part, indirect. Hybridization in situ revealed that KAP mRNA expression was restricted to proximal tubule epithelial cells in the juxtamedullary region of castrated animals rather than throughout the cortex as in intact males. Examination of sections of kidneys from Tfm/Y mice before and after testosterone (T) treatment revealed that only the juxtamedullary tubules expressed KAP mRNA and that T increased the level of KAP mRNA in these cells. Treatment of Tfm/Y animals with other steroids showed that beta-estradiol treatment mimicked the effect of T while dihydrotestosterone (DHT) had no effect. The facts that DHT and T both stimulate cortical expression of KAP mRNA in normal animals but DHT has no effect on the juxtamedullary cells in the Tfm/Y variant may indicate that the action of T is due to an estrogenic metabolite. Castrated, hypophysectomized males exhibited no KAP gene expression, while in the presence of T, expression was observed throughout the cortex as in intact males. These results clearly indicate the involvement of pituitary hormones in KAP gene expression in the juxtamedullary tubules. These studies have shown that the regulation of KAP gene expression in the mouse kidney is much more complex than originally believed. Future studies will further investigate the roles of estrogen and specific pituitary hormones in KAP gene expression.
Meseguer
A
A
Population Council, Rockefeller University, New York, N.Y. 10021.
Catterall
J F
JF
D013734:Androgen-Insensitivity Syndrome / Q000235:genetics / Q000378:metabolism; D000818:Animals; D013196:Dihydrotestosterone / Q000494:pharmacology; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D007016:Hypophysectomy; D007687:Kidney Tubules, Proximal / Q000378:metabolism* / Q000648:ultrastructure; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D008817:Mice, Mutant Strains; D009693:Nucleic Acid Hybridization; D009919:Orchiectomy; D011061:Poly A / Q000096:biosynthesis*; D014176:Protein Biosynthesis; D011506:Proteins / Q000235:genetics*; D012313:RNA; D015347:RNA Probes; D016372:RNA, Antisense; D012333:RNA, Messenger / Q000096:biosynthesis*; D011944:Receptors, Androgen / Q000172:deficiency / Q000502:physiology*; D013739:Testosterone / Q000494:pharmacology*
D011506:Proteins; D015347:RNA Probes; D016372:RNA, Antisense; D012333:RNA, Messenger; D011944:Receptors, Androgen; D013196:Dihydrotestosterone; D011061:Poly A; D013739:Testosterone; D004958:Estradiol; D012313:RNA